Tradipitant
VP-VLY-686-3404
Phase 3 small_molecule active
Quick answer
Tradipitant for Motion Sickness is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Motion Sickness
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active